CHILDHOOD ABSENCE EPILEPSY: RX, PK-PD-PHARMACOGENETICS

儿童失神癫痫：RX、PK-PD-药物遗传学

• 批准号: 7374209
• 负责人: DORIS A TRAUNER
• 金额: $ 4.05万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7374209
• 关键词: anticonvulsants; children; epilepsy; anticonvulsants; children; epilepsy

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Identify the optimal anticonvulsant used for the intitial treatment of children with Childhood Absence Epilepsy.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员（PI）可能已经从其他NIH来源获得了主要资金，因此可以在其他清晰的条目中代表。列出的机构适用于该中心，这不一定是调查员的机构。确定用于对儿童缺席癫痫病儿童进行耐心治疗的最佳抗惊厥药。